Xiaobin Wu insider trades

Open-market stock purchases and sales by Xiaobin Wu, President and COO at BeOne Medicines Ltd, from SEC Form 4 filings since Jul 1, 2015.

Recent trades

DateStockTradeValue
Aug 25, 2026ONC BeOne Medicines LtdSold$106K
Jun 23, 2026ONC BeOne Medicines LtdSold$357K
Jun 16, 2026ONC BeOne Medicines LtdSold$362K
Jun 11, 2026ONC BeOne Medicines LtdBought (not open market)—
Jun 11, 2026ONC BeOne Medicines LtdSold$164K
Jun 11, 2026ONC BeOne Medicines LtdBought (not open market)—
Jun 8, 2026ONC BeOne Medicines LtdSold$10.8K
Jun 8, 2026ONC BeOne Medicines LtdSold$389K
Mar 6, 2026ONC BeOne Medicines LtdBought (not open market)—
Mar 6, 2026ONC BeOne Medicines LtdBought (not open market)—
Nov 17, 2025ONC BeOne Medicines LtdSold$1.2M
Nov 17, 2025ONC BeOne Medicines LtdSold$315K
Nov 17, 2025ONC BeOne Medicines LtdSold$3.8K
Nov 13, 2025ONC BeOne Medicines LtdSold$1.6M
Nov 13, 2025ONC BeOne Medicines LtdSold$674K
Nov 12, 2025ONC BeOne Medicines LtdSold$175K
Nov 12, 2025ONC BeOne Medicines LtdSold$1.1M
Nov 12, 2025ONC BeOne Medicines LtdSold$278K
Nov 12, 2025ONC BeOne Medicines LtdSold$88.9K
Nov 12, 2025ONC BeOne Medicines LtdSold$42.6K
Nov 12, 2025ONC BeOne Medicines LtdSold$35.7K
Nov 12, 2025ONC BeOne Medicines LtdSold$1.7M
Nov 12, 2025ONC BeOne Medicines LtdSold$55.8K

Companies traded

  • ONC BeOne Medicines Ltd: 42 sales, last Aug 25, 2026
  • BGNE BeiGene, Ltd: 93 sales, last Apr 1, 2025
  • NONE Fuda Group (USA) Corp: 2 buys, 2 sales, last Sep 28, 2015

Get free alerts when Xiaobin Wu files a new trade →